ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Anti-Infective Drugs Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-21F19050
Home | Market Reports | Health| Pharmacy
Global Pediatric Anti Infective Drugs Market Research Report 2025
BUY CHAPTERS

Global Pediatric Anti-Infective Drugs Market Research Report 2025

Code: QYRE-Auto-21F19050
Report
March 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Merck
Pfizer Inc
Mylan NV
Novartis
BristolMyers Squibb
AbbVie
Johnson and Johnson
Bayer
Teva Pharmaceuticals
GlaxoSmithKline PLC
Amgen Inc
Eli Lilly
Sanofi
Astrazeneca plc
China Resources Sanjiu Medical & Pharmaceutical
Jichuan Pharmaceutical
SINOVAC BIOTECH
Kangzhi Pharmaceutical
Daiyin Pharmaceutical
KuiHua Pharmaceutical

Pediatric Anti-Infective Drugs Market Size

The global market for Pediatric Anti-Infective Drugs was valued at US$ 10000 million in the year 2024 and is projected to reach a revised size of US$ 12330 million by 2031, growing at a CAGR of 3.0% during the forecast period.

Pediatric Anti-Infective Drugs Market

Pediatric Anti-Infective Drugs Market

Pediatric anti-infective drugs refer to drugs specially used to prevent and treat infectious diseases in children (usually 0-18 years old). These drugs exert their effects by inhibiting or killing pathogens (such as bacteria, viruses, fungi, parasites, etc.), and their development and use need to fully consider the physiological characteristics of children, the metabolic characteristics of drugs, and the suitability of dosage forms to ensure efficacy and safety.
The main driving factors for this growth include the increasing prevalence of pediatric diseases, advances in pediatric drug development, and increased awareness of pediatric health. In addition, factors such as the government's attention and support for the children's healthcare system, the increasing demand for personalized pediatric medicine, and the widespread use of telemedicine are also promoting the expansion of the market. The global pediatric anti-infective drug market is highly competitive, and major participating companies such as Roche, Merck, Pfizer, Mylan, Novartis, etc. are striving to innovate and develop targeted therapies to meet the unique physiological and developmental needs of children. In addition to investing heavily in technology research and development, enterprises actively expand their product portfolio and market scope, and extensively cooperate with enterprises, medical, academic, and government institutions. The global pediatric anti-infective drug market is steadily growing in various regions, with North America leading the way, followed by Europe, the Asia Pacific region, and South America with smaller market shares but enormous potential. In the next few years, patient-centered and uniquely designed innovative drugs will be the trend in the market.
This report aims to provide a comprehensive presentation of the global market for Pediatric Anti-Infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Anti-Infective Drugs.
The Pediatric Anti-Infective Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Anti-Infective Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Anti-Infective Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pediatric Anti-Infective Drugs Market Report

Report Metric Details
Report Name Pediatric Anti-Infective Drugs Market
Accounted market size in year US$ 10000 million
Forecasted market size in 2031 US$ 12330 million
CAGR 3.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Antibiotics
  • Antiviral Drugs
  • Antifungal Agents
  • Antiparasitic Agents
  • Immune Modulators
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Merck, Pfizer, Mylan, Novartis, BristolMyers Squibb, AbbVie, Johnson and Johnson, Bayer, Teva Pharmaceuticals, GlaxoSmithKline, Amgen, Eli Lilly, Sanofi, AstraZeneca, China Resources Sanjiu Medical & Pharmaceutical, Jichuan Pharmaceutical, Sinovac Biotech, Daiyin Pharmaceutical, KuiHua Pharmaceutical, Kangzhi Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pediatric Anti-Infective Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pediatric Anti-Infective Drugs Market growing?

Ans: The Pediatric Anti-Infective Drugs Market witnessing a CAGR of 3.0% during the forecast period 2025-2031.

What is the Pediatric Anti-Infective Drugs Market size in 2031?

Ans: The Pediatric Anti-Infective Drugs Market size in 2031 will be US$ 12330 million.

Who are the main players in the Pediatric Anti-Infective Drugs Market report?

Ans: The main players in the Pediatric Anti-Infective Drugs Market are Roche, Merck, Pfizer, Mylan, Novartis, BristolMyers Squibb, AbbVie, Johnson and Johnson, Bayer, Teva Pharmaceuticals, GlaxoSmithKline, Amgen, Eli Lilly, Sanofi, AstraZeneca, China Resources Sanjiu Medical & Pharmaceutical, Jichuan Pharmaceutical, Sinovac Biotech, Daiyin Pharmaceutical, KuiHua Pharmaceutical, Kangzhi Pharmaceutical

What are the Application segmentation covered in the Pediatric Anti-Infective Drugs Market report?

Ans: The Applications covered in the Pediatric Anti-Infective Drugs Market report are Hospital, Clinic, Pharmacy, Others

What are the Type segmentation covered in the Pediatric Anti-Infective Drugs Market report?

Ans: The Types covered in the Pediatric Anti-Infective Drugs Market report are Antibiotics, Antiviral Drugs, Antifungal Agents, Antiparasitic Agents, Immune Modulators, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Anti-Infective Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibiotics
1.2.3 Antiviral Drugs
1.2.4 Antifungal Agents
1.2.5 Antiparasitic Agents
1.2.6 Immune Modulators
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pediatric Anti-Infective Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Anti-Infective Drugs Market Perspective (2020-2031)
2.2 Global Pediatric Anti-Infective Drugs Growth Trends by Region
2.2.1 Global Pediatric Anti-Infective Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Anti-Infective Drugs Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Anti-Infective Drugs Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Anti-Infective Drugs Market Dynamics
2.3.1 Pediatric Anti-Infective Drugs Industry Trends
2.3.2 Pediatric Anti-Infective Drugs Market Drivers
2.3.3 Pediatric Anti-Infective Drugs Market Challenges
2.3.4 Pediatric Anti-Infective Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Anti-Infective Drugs Players by Revenue
3.1.1 Global Top Pediatric Anti-Infective Drugs Players by Revenue (2020-2025)
3.1.2 Global Pediatric Anti-Infective Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top Pediatric Anti-Infective Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Anti-Infective Drugs Revenue
3.4 Global Pediatric Anti-Infective Drugs Market Concentration Ratio
3.4.1 Global Pediatric Anti-Infective Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Anti-Infective Drugs Revenue in 2024
3.5 Global Key Players of Pediatric Anti-Infective Drugs Head office and Area Served
3.6 Global Key Players of Pediatric Anti-Infective Drugs, Product and Application
3.7 Global Key Players of Pediatric Anti-Infective Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Anti-Infective Drugs Breakdown Data by Type
4.1 Global Pediatric Anti-Infective Drugs Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Anti-Infective Drugs Forecasted Market Size by Type (2026-2031)
5 Pediatric Anti-Infective Drugs Breakdown Data by Application
5.1 Global Pediatric Anti-Infective Drugs Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Anti-Infective Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Anti-Infective Drugs Market Size (2020-2031)
6.2 North America Pediatric Anti-Infective Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Anti-Infective Drugs Market Size by Country (2020-2025)
6.4 North America Pediatric Anti-Infective Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Anti-Infective Drugs Market Size (2020-2031)
7.2 Europe Pediatric Anti-Infective Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Anti-Infective Drugs Market Size by Country (2020-2025)
7.4 Europe Pediatric Anti-Infective Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Anti-Infective Drugs Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Anti-Infective Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Anti-Infective Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Anti-Infective Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Anti-Infective Drugs Market Size (2020-2031)
9.2 Latin America Pediatric Anti-Infective Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Anti-Infective Drugs Market Size by Country (2020-2025)
9.4 Latin America Pediatric Anti-Infective Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Anti-Infective Drugs Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Anti-Infective Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Anti-Infective Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Anti-Infective Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Pediatric Anti-Infective Drugs Introduction
11.1.4 Roche Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Pediatric Anti-Infective Drugs Introduction
11.2.4 Merck Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatric Anti-Infective Drugs Introduction
11.3.4 Pfizer Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Pediatric Anti-Infective Drugs Introduction
11.4.4 Mylan Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.4.5 Mylan Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Pediatric Anti-Infective Drugs Introduction
11.5.4 Novartis Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 BristolMyers Squibb
11.6.1 BristolMyers Squibb Company Details
11.6.2 BristolMyers Squibb Business Overview
11.6.3 BristolMyers Squibb Pediatric Anti-Infective Drugs Introduction
11.6.4 BristolMyers Squibb Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.6.5 BristolMyers Squibb Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Pediatric Anti-Infective Drugs Introduction
11.7.4 AbbVie Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.7.5 AbbVie Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Pediatric Anti-Infective Drugs Introduction
11.8.4 Johnson and Johnson Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.8.5 Johnson and Johnson Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Pediatric Anti-Infective Drugs Introduction
11.9.4 Bayer Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Teva Pharmaceuticals
11.10.1 Teva Pharmaceuticals Company Details
11.10.2 Teva Pharmaceuticals Business Overview
11.10.3 Teva Pharmaceuticals Pediatric Anti-Infective Drugs Introduction
11.10.4 Teva Pharmaceuticals Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.10.5 Teva Pharmaceuticals Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Pediatric Anti-Infective Drugs Introduction
11.11.4 GlaxoSmithKline Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.11.5 GlaxoSmithKline Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Pediatric Anti-Infective Drugs Introduction
11.12.4 Amgen Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.12.5 Amgen Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Pediatric Anti-Infective Drugs Introduction
11.13.4 Eli Lilly Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.13.5 Eli Lilly Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Pediatric Anti-Infective Drugs Introduction
11.14.4 Sanofi Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.14.5 Sanofi Recent Development
11.15 AstraZeneca
11.15.1 AstraZeneca Company Details
11.15.2 AstraZeneca Business Overview
11.15.3 AstraZeneca Pediatric Anti-Infective Drugs Introduction
11.15.4 AstraZeneca Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.15.5 AstraZeneca Recent Development
11.16 China Resources Sanjiu Medical & Pharmaceutical
11.16.1 China Resources Sanjiu Medical & Pharmaceutical Company Details
11.16.2 China Resources Sanjiu Medical & Pharmaceutical Business Overview
11.16.3 China Resources Sanjiu Medical & Pharmaceutical Pediatric Anti-Infective Drugs Introduction
11.16.4 China Resources Sanjiu Medical & Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.16.5 China Resources Sanjiu Medical & Pharmaceutical Recent Development
11.17 Jichuan Pharmaceutical
11.17.1 Jichuan Pharmaceutical Company Details
11.17.2 Jichuan Pharmaceutical Business Overview
11.17.3 Jichuan Pharmaceutical Pediatric Anti-Infective Drugs Introduction
11.17.4 Jichuan Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.17.5 Jichuan Pharmaceutical Recent Development
11.18 Sinovac Biotech
11.18.1 Sinovac Biotech Company Details
11.18.2 Sinovac Biotech Business Overview
11.18.3 Sinovac Biotech Pediatric Anti-Infective Drugs Introduction
11.18.4 Sinovac Biotech Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.18.5 Sinovac Biotech Recent Development
11.19 Daiyin Pharmaceutical
11.19.1 Daiyin Pharmaceutical Company Details
11.19.2 Daiyin Pharmaceutical Business Overview
11.19.3 Daiyin Pharmaceutical Pediatric Anti-Infective Drugs Introduction
11.19.4 Daiyin Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.19.5 Daiyin Pharmaceutical Recent Development
11.20 KuiHua Pharmaceutical
11.20.1 KuiHua Pharmaceutical Company Details
11.20.2 KuiHua Pharmaceutical Business Overview
11.20.3 KuiHua Pharmaceutical Pediatric Anti-Infective Drugs Introduction
11.20.4 KuiHua Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.20.5 KuiHua Pharmaceutical Recent Development
11.21 Kangzhi Pharmaceutical
11.21.1 Kangzhi Pharmaceutical Company Details
11.21.2 Kangzhi Pharmaceutical Business Overview
11.21.3 Kangzhi Pharmaceutical Pediatric Anti-Infective Drugs Introduction
11.21.4 Kangzhi Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025)
11.21.5 Kangzhi Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Merck
Pfizer Inc
Mylan NV
Novartis
BristolMyers Squibb
AbbVie
Johnson and Johnson
Bayer
Teva Pharmaceuticals
GlaxoSmithKline PLC
Amgen Inc
Eli Lilly
Sanofi
Astrazeneca plc
China Resources Sanjiu Medical & Pharmaceutical
Jichuan Pharmaceutical
SINOVAC BIOTECH
Kangzhi Pharmaceutical
Daiyin Pharmaceutical
KuiHua Pharmaceutical
List of Tables
 Table 1. Global Pediatric Anti-Infective Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antibiotics
 Table 3. Key Players of Antiviral Drugs
 Table 4. Key Players of Antifungal Agents
 Table 5. Key Players of Antiparasitic Agents
 Table 6. Key Players of Immune Modulators
 Table 7. Key Players of Others
 Table 8. Global Pediatric Anti-Infective Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Pediatric Anti-Infective Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Pediatric Anti-Infective Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Pediatric Anti-Infective Drugs Market Share by Region (2020-2025)
 Table 12. Global Pediatric Anti-Infective Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Pediatric Anti-Infective Drugs Market Share by Region (2026-2031)
 Table 14. Pediatric Anti-Infective Drugs Market Trends
 Table 15. Pediatric Anti-Infective Drugs Market Drivers
 Table 16. Pediatric Anti-Infective Drugs Market Challenges
 Table 17. Pediatric Anti-Infective Drugs Market Restraints
 Table 18. Global Pediatric Anti-Infective Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Pediatric Anti-Infective Drugs Market Share by Players (2020-2025)
 Table 20. Global Top Pediatric Anti-Infective Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Anti-Infective Drugs as of 2024)
 Table 21. Ranking of Global Top Pediatric Anti-Infective Drugs Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Pediatric Anti-Infective Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Pediatric Anti-Infective Drugs, Headquarters and Area Served
 Table 24. Global Key Players of Pediatric Anti-Infective Drugs, Product and Application
 Table 25. Global Key Players of Pediatric Anti-Infective Drugs, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Pediatric Anti-Infective Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Pediatric Anti-Infective Drugs Revenue Market Share by Type (2020-2025)
 Table 29. Global Pediatric Anti-Infective Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Pediatric Anti-Infective Drugs Revenue Market Share by Type (2026-2031)
 Table 31. Global Pediatric Anti-Infective Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Pediatric Anti-Infective Drugs Revenue Market Share by Application (2020-2025)
 Table 33. Global Pediatric Anti-Infective Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Pediatric Anti-Infective Drugs Revenue Market Share by Application (2026-2031)
 Table 35. North America Pediatric Anti-Infective Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Pediatric Anti-Infective Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Pediatric Anti-Infective Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Pediatric Anti-Infective Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Pediatric Anti-Infective Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Pediatric Anti-Infective Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Pediatric Anti-Infective Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Pediatric Anti-Infective Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Pediatric Anti-Infective Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Pediatric Anti-Infective Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Pediatric Anti-Infective Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Pediatric Anti-Infective Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Pediatric Anti-Infective Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Pediatric Anti-Infective Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Pediatric Anti-Infective Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Roche Company Details
 Table 51. Roche Business Overview
 Table 52. Roche Pediatric Anti-Infective Drugs Product
 Table 53. Roche Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 54. Roche Recent Development
 Table 55. Merck Company Details
 Table 56. Merck Business Overview
 Table 57. Merck Pediatric Anti-Infective Drugs Product
 Table 58. Merck Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 59. Merck Recent Development
 Table 60. Pfizer Company Details
 Table 61. Pfizer Business Overview
 Table 62. Pfizer Pediatric Anti-Infective Drugs Product
 Table 63. Pfizer Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 64. Pfizer Recent Development
 Table 65. Mylan Company Details
 Table 66. Mylan Business Overview
 Table 67. Mylan Pediatric Anti-Infective Drugs Product
 Table 68. Mylan Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 69. Mylan Recent Development
 Table 70. Novartis Company Details
 Table 71. Novartis Business Overview
 Table 72. Novartis Pediatric Anti-Infective Drugs Product
 Table 73. Novartis Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 74. Novartis Recent Development
 Table 75. BristolMyers Squibb Company Details
 Table 76. BristolMyers Squibb Business Overview
 Table 77. BristolMyers Squibb Pediatric Anti-Infective Drugs Product
 Table 78. BristolMyers Squibb Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 79. BristolMyers Squibb Recent Development
 Table 80. AbbVie Company Details
 Table 81. AbbVie Business Overview
 Table 82. AbbVie Pediatric Anti-Infective Drugs Product
 Table 83. AbbVie Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 84. AbbVie Recent Development
 Table 85. Johnson and Johnson Company Details
 Table 86. Johnson and Johnson Business Overview
 Table 87. Johnson and Johnson Pediatric Anti-Infective Drugs Product
 Table 88. Johnson and Johnson Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 89. Johnson and Johnson Recent Development
 Table 90. Bayer Company Details
 Table 91. Bayer Business Overview
 Table 92. Bayer Pediatric Anti-Infective Drugs Product
 Table 93. Bayer Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 94. Bayer Recent Development
 Table 95. Teva Pharmaceuticals Company Details
 Table 96. Teva Pharmaceuticals Business Overview
 Table 97. Teva Pharmaceuticals Pediatric Anti-Infective Drugs Product
 Table 98. Teva Pharmaceuticals Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 99. Teva Pharmaceuticals Recent Development
 Table 100. GlaxoSmithKline Company Details
 Table 101. GlaxoSmithKline Business Overview
 Table 102. GlaxoSmithKline Pediatric Anti-Infective Drugs Product
 Table 103. GlaxoSmithKline Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 104. GlaxoSmithKline Recent Development
 Table 105. Amgen Company Details
 Table 106. Amgen Business Overview
 Table 107. Amgen Pediatric Anti-Infective Drugs Product
 Table 108. Amgen Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 109. Amgen Recent Development
 Table 110. Eli Lilly Company Details
 Table 111. Eli Lilly Business Overview
 Table 112. Eli Lilly Pediatric Anti-Infective Drugs Product
 Table 113. Eli Lilly Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 114. Eli Lilly Recent Development
 Table 115. Sanofi Company Details
 Table 116. Sanofi Business Overview
 Table 117. Sanofi Pediatric Anti-Infective Drugs Product
 Table 118. Sanofi Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 119. Sanofi Recent Development
 Table 120. AstraZeneca Company Details
 Table 121. AstraZeneca Business Overview
 Table 122. AstraZeneca Pediatric Anti-Infective Drugs Product
 Table 123. AstraZeneca Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 124. AstraZeneca Recent Development
 Table 125. China Resources Sanjiu Medical & Pharmaceutical Company Details
 Table 126. China Resources Sanjiu Medical & Pharmaceutical Business Overview
 Table 127. China Resources Sanjiu Medical & Pharmaceutical Pediatric Anti-Infective Drugs Product
 Table 128. China Resources Sanjiu Medical & Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 129. China Resources Sanjiu Medical & Pharmaceutical Recent Development
 Table 130. Jichuan Pharmaceutical Company Details
 Table 131. Jichuan Pharmaceutical Business Overview
 Table 132. Jichuan Pharmaceutical Pediatric Anti-Infective Drugs Product
 Table 133. Jichuan Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 134. Jichuan Pharmaceutical Recent Development
 Table 135. Sinovac Biotech Company Details
 Table 136. Sinovac Biotech Business Overview
 Table 137. Sinovac Biotech Pediatric Anti-Infective Drugs Product
 Table 138. Sinovac Biotech Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 139. Sinovac Biotech Recent Development
 Table 140. Daiyin Pharmaceutical Company Details
 Table 141. Daiyin Pharmaceutical Business Overview
 Table 142. Daiyin Pharmaceutical Pediatric Anti-Infective Drugs Product
 Table 143. Daiyin Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 144. Daiyin Pharmaceutical Recent Development
 Table 145. KuiHua Pharmaceutical Company Details
 Table 146. KuiHua Pharmaceutical Business Overview
 Table 147. KuiHua Pharmaceutical Pediatric Anti-Infective Drugs Product
 Table 148. KuiHua Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 149. KuiHua Pharmaceutical Recent Development
 Table 150. Kangzhi Pharmaceutical Company Details
 Table 151. Kangzhi Pharmaceutical Business Overview
 Table 152. Kangzhi Pharmaceutical Pediatric Anti-Infective Drugs Product
 Table 153. Kangzhi Pharmaceutical Revenue in Pediatric Anti-Infective Drugs Business (2020-2025) & (US$ Million)
 Table 154. Kangzhi Pharmaceutical Recent Development
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. Authors List of This Report


List of Figures
 Figure 1. Pediatric Anti-Infective Drugs Picture
 Figure 2. Global Pediatric Anti-Infective Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pediatric Anti-Infective Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Antibiotics Features
 Figure 5. Antiviral Drugs Features
 Figure 6. Antifungal Agents Features
 Figure 7. Antiparasitic Agents Features
 Figure 8. Immune Modulators Features
 Figure 9. Others Features
 Figure 10. Global Pediatric Anti-Infective Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Pediatric Anti-Infective Drugs Market Share by Application: 2024 VS 2031
 Figure 12. Hospital Case Studies
 Figure 13. Clinic Case Studies
 Figure 14. Pharmacy Case Studies
 Figure 15. Others Case Studies
 Figure 16. Pediatric Anti-Infective Drugs Report Years Considered
 Figure 17. Global Pediatric Anti-Infective Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Pediatric Anti-Infective Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Pediatric Anti-Infective Drugs Market Share by Region: 2024 VS 2031
 Figure 20. Global Pediatric Anti-Infective Drugs Market Share by Players in 2024
 Figure 21. Global Pediatric Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 22. The Top 10 and 5 Players Market Share by Pediatric Anti-Infective Drugs Revenue in 2024
 Figure 23. North America Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Pediatric Anti-Infective Drugs Market Share by Country (2020-2031)
 Figure 25. United States Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Pediatric Anti-Infective Drugs Market Share by Country (2020-2031)
 Figure 29. Germany Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Pediatric Anti-Infective Drugs Market Share by Region (2020-2031)
 Figure 37. China Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Pediatric Anti-Infective Drugs Market Share by Country (2020-2031)
 Figure 45. Mexico Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Pediatric Anti-Infective Drugs Market Share by Country (2020-2031)
 Figure 49. Turkey Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Pediatric Anti-Infective Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Roche Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 54. Pfizer Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 55. Mylan Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 57. BristolMyers Squibb Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 58. AbbVie Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 59. Johnson and Johnson Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 60. Bayer Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 62. GlaxoSmithKline Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 63. Amgen Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 64. Eli Lilly Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 65. Sanofi Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 66. AstraZeneca Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 67. China Resources Sanjiu Medical & Pharmaceutical Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 68. Jichuan Pharmaceutical Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 69. Sinovac Biotech Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 70. Daiyin Pharmaceutical Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 71. KuiHua Pharmaceutical Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 72. Kangzhi Pharmaceutical Revenue Growth Rate in Pediatric Anti-Infective Drugs Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Ibuprofen Sodium​ API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30X13296
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11U13426
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-16160
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-10G2665
Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions